Boro-Scopol

규격

51-34-3CAS 번호

[(1S,2S,4R,5R)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoateIUPAC 명칭

C17H21NO4화학식

303.35 g/mol분자량

Scopace; Boro-Scopol; RefChem:570028; scopolamine; Hyoscine; (-)-Hyoscine; 51-34-3; Scopine tropate; Transderm-Scop; (-)-Scopolamine; Scopine (-)-tropate; Atrochin; Atroquin; Hyosol; l-Scopolamine; 6,7-Epoxytropine tropate; Epoxytropine tropate; Isopto Hyoscine; Beldavrin; Scopamin; alpha-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(2.4))non-7-yl ester; Skopolamin; Hyosceine; Transcop; Scop; DL48G20X8X; Tropic acid, ester with scopine; CHEMBL3084722; Euscopol; Isoscopil; Tranaxine; (1S,3S,5R,6R,7S)-6,7-epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate; Kwells; Hysco; Hyoscine bromide; Scopolamine HCl; Hyoscine hydrobromide; Scopolaminium bromide; 1alphaH,5alphaH-Tropan-3alpha-ol, 6beta,7beta-epoxy-, (-)-tropate (ester); Scopolammonium bromide; l-Hyoscine hydrobromide; (1R,2R,4S,5S,7s)-9-Methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate; SEE; (-)-Scopolamine bromide; l-Scopolamine-hydrobromide; SCOPOLAMINE BROMIDE; (-)-Hyoscine hydrobromide; Scopoderm; levo-duboisine; Transderm scop; (+)-Hyoscine; CHEMBL4065982; (1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0(2,4)]non-7-yl (2S)-3-hydroxy-2-phenylpropanoate; (1R,2R,4S,5S,7s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl (S)-3-hydroxy-2-phenylpropanoate; Hyoscyine hydrobromide; Hydroscine hydrobromide; hydrobromicum, Scopolaminum; UNII-DL48G20X8X; Tropane alkaloid; HSDB 4074; Hyoscine CRS; 6.beta.,7.beta.-Epoxy-1.alpha.H,5.alpha.H-tropan-3.alpha.-ol (-)-tropate (ester); EINECS 200-090-3; NSC61806; S-(-)-Tropate; Atropine EP Impurity F; SCOPOLAMINE [MI]; Prestwick3_000877; HYOSCINE [MART.]; SCOPOLAMINE [HSDB]; HYOSCINE [WHO-DD]; EC 200-090-3; SCOPOLAMINE [VANDF]; (-)-Scopolamin (Hyoscine); 6beta,7beta-Epoxy-3alpha-tropanyl S-(-)-tropate; SCHEMBL16226; BSPBio_000953; GTPL330; 6beta,7beta-Epoxy-1alpha,5alpha-tropan-3alpha-ol; HYOSCINE [EP IMPURITY]; BPBio1_001049; CHEMBL569713; HYOSCINE [EP MONOGRAPH]; CHEMBL1906925; DTXSID6023573; SCHEMBL22393238; SCHEMBL29349990; CHEBI:16794; CHEBI:93572; SCOPOLAMINE [ORANGE BOOK]; STECJAGHUSJQJN-FWXGHANASA-N; HMS2090N13; HMS3886L22; SCOPOLAMINE [USP IMPURITY]; HY-N0296; LSM-4015; MSK10286; AC-968; BDBM50248295; BDBM50263508; EBC-12877; s9326; AKOS025402477; Scopolamine dried down 100 microg/mL; Tropic acid, 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(sup 2,4))non-7-yl ester; CCG-267504; CS-6609; DB00747; FS16424; T3S0478; 3-Oxa-9-azatricyclo(3.3.1.0(sup 2,4))nonan-7-ol, 9-methyl-, tropate (ester); 3-Oxa-9-azatricyclo(3.3.1.O(sup 2,4))nonan-7-ol, 9-methyl-, tropate (ester); SMP1_000270; NCGC00024357-04; NCGC00024357-05; DA-67494; Scopolamine 100 microg/mL in Acetonitrile; AB00429689; AB00429689-30; AB00429689-31; AB00429689_32; EN300-1718536; ATROPINE SULFATE IMPURITY F [EP IMPURITY]; Q337188; (methyl[?]yl) (2S)-3-hydroxy-2-phenyl-propanoate; BRD-K89923877-003-02-4; BRD-K89923877-004-15-4; BRD-K89923877-004-16-2; Q27165268; Atropine Sulfate EP Impurity F; Hyoscine; Hyoscyamine EP Impurity D; (1R,2R,4S,5S,7R)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0,2,4]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate; (1R,2R,4S,5S,7R)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0,nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate; (1R,2R,4S,5S,7S)-9-METHYL-3-OXA-9-AZATRICYCLO(3.3.1.02,4)NON-7-YL (2S)-3-HYDROXY-2-PHENYLPROPANOATE; (1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate; (1R,2R,4S,5S,7S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]non-7-yl (2S)-3-hydroxy-2-phenylpropanoate; (1R,2R,4S,5S,7s)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate; [(1R,2R,4S,5S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenyl-propanoate; [(1R,2R,4S,5S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate; [7(S)-(1.alpha.,2.beta.,4.beta.,5.alpha.,7.beta.)]-.alpha.-(Hydroxymethyl)benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo-[3.3.1.0^2,4]non-7-yl ester; BENZENEACETIC ACID, .ALPHA.(HYDROXYMETHYL)-,(1.ALPHA.,2.BETA.,4.BETA.,5.ALPHA.,7.BETA.)-9-METHYL-3-OXA-9-AZATRICYCLO(3.3.1.02,4)NON-7-YL ESTER, (.ALPHA.S)-; BENZENEACETIC ACID, .ALPHA.-(HYDROXYMETHYL)-, 9-METHYL-3-OXA-9-AZATRICYCLO(3.3.1.02,4)NON-7-YL ESTER, (7(S)-(1.ALPHA.,2.BETA.,4.BETA.,5.ALPHA.,7.BETA.))-; Benzeneacetic acid, alpha-(hydroxymethyl)-, (1alpha,2beta,4beta,5alpha,7beta)-9-methyl-3-oxa-9-azatricyclo(3.3.1.02,4)non-7-yl ester, (alphaS)-; Benzeneacetic acid, alpha-(hydroxymethyl)-, 9-methyl-3-oxa-9-azatricyclo(3.3.1.02,4)non-7-yl ester, (7(S)-(1alpha,2beta,4beta,5alpha,7beta))-; OW0동의어